Teriflunomide NEW
| Price | $45 | $58 | $90 |
| Package | 10mg | 50mg | 100mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-09-29 |
Product Details
| Product Name: Teriflunomide | CAS No.: 163451-81-8 |
| Purity: 99.95% | Supply Ability: 10g |
| Release date: 2025/09/29 |
Product Introduction
Bioactivity
| Name | Teriflunomide |
| Description | Teriflunomide (A 77-1726) is the principal active metabolite of leflunomide, an approved therapy for rheumatoid arthritis and multiple sclerosis. |
| In vitro | Teriflunomide primarily acts as an inhibitor of dihydroorotate dehydrogenase (DHODH), a key mitochondrial enzyme involved in the de novo synthesis of pyrimidines in rapidly proliferating cells. By reducing the activity of high-avidity proliferating T lymphocytes and B lymphocytes, teriflunomide likely attenuates the inflammatory response to autoantigens in MS. Notably, DHODH blockade does not affect resting or homeostatically proliferating hematopoietic cell lines, as pyrimidine pools in these cells can be generated through an alternate 'salvage pathway,' which is independent of DHODH. Thus, teriflunomide can be considered a cytostatic rather than a cytotoxic drug to leukocytes [1]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 26 mg/mL (96.22 mM), Sonication is recommended. |
| Keywords | Teriflunomide | Inhibitor | inhibit | A77 1726 |
| Inhibitors Related | Melamine | Mycophenolate Mofetil | Clozapine N-Oxide | L-Threonic acid magnesium salt | SN-38 | Isonicotinic acid | Urolithin A | Ampyrone | Lansoprazole sulfide | Tulipalin A | 4-(4-Amino-3-fluorophenoxy)-N-methylpicolinamide | Nicotinamide N-oxide |
| Related Compound Libraries | FDA-Approved & Pharmacopeia Drug Library | Failed Clinical Trials Compound Library | Bioactive Compound Library | EMA Approved Drug Library | Drug Repurposing Compound Library | Anti-Viral Compound Library | FDA-Approved Drug Library | Orally Active Compound Library | Immunology/Inflammation Compound Library | Clinical Compound Library | Bioactive Compounds Library Max | Drug Metabolite/Impurity Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $0.00/1kg |
VIP5Y
|
Sinoway Industrial co., ltd.
|
2025-05-23 | |
| $0.00/1g |
VIP2Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2024-10-11 | |
| $3.00/1kg |
Hebei Fengjia New Material Co., Ltd
|
2024-09-03 | ||
| $0.00/1Kg/Bag |
VIP5Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2021-11-08 | |
| $285.00/1g |
Wuhan Nutra Biotechnology Co.,Ltd
|
2021-05-23 | ||
| $1.00/1KG |
VIP8Y
|
Career Henan Chemical Co
|
2018-08-15 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY